Stay updated on 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial

Sign up to get notified when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Record History shows updates to the study's status over time, including changes to Study Status. A Recruitment Status entry appears in 2024-05-28, reflecting changes in trial recruitment.
    Difference
    0.1%
    Check dated 2025-11-03T21:07:54.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T06:36:12.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:14:57.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' link was removed, a minor UI change with no substantive updates to core content.
    Difference
    0.7%
    Check dated 2025-09-14T21:36:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-07T17:41:38.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-31T12:19:33.000Z thumbnail image

Stay in the know with updates to 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.